Bristol-Myers Squibb Foundation’s $25M Commitment to Cancer Moonshot Recognized at AACR Annual Meeting
Primary tabs
Bristol-Myers Squibb Foundation’s $25M Commitment to Cancer Moonshot Recognized at AACR Annual Meeting
tweet me:
Bristol-Myers Squibb recognized for $25M commitment to Cancer Moonshot http://bit.ly/2JPxtt3 @AACR @BMSnews
Tuesday, April 17, 2018 - 4:40pm
The Bristol-Myers Squibb Foundation’s commitment to address health disparities in cancer outcomes and care was represented at the Biden Cancer Initiative event at AACR. In 2016, the Foundation joined the Cancer Moonshot initiative and donated $25M to grantee projects to expand community-based cancer care resources and patient engagement and support programs for racial and ethnic minorities, rural, low income and vulnerable populations in the U.S. Grantee projects are being implemented in over 25 states across the country.
Keywords: Philanthropy & Cause Initiatives | American Association for Cancer Research | Biden Cancer Initiative | Bristol-Myers Squibb | Cancer Moonshot | Chronic Illness | Grants | Health & Healthcare | Healthcare Industry News | Improving Healthcare Access | Research & Policy
More From Bristol-Myers Squibb Company
Thursday, April 19, 2018 - 2:00pm
Monday, April 2, 2018 - 10:15am